posted on 2023-06-01, 20:44authored byHeli Tirkkonen, Katelyn V. Brown, Magdalena Niemczura, Zélie Faudemer, Courtney Brown, Larissa V. Ponomareva, Yosra A. Helmy, Jon S. Thorson, S. Eric Nybo, Mikko Metsä-Ketelä, Khaled A. Shaaban
Tetracenomycins and
elloramycins are polyketide natural products
produced by several actinomycetes that exhibit antibacterial and anticancer
activities. They inhibit ribosomal translation by binding in the polypeptide
exit channel of the large ribosomal subunit. The tetracenomycins and
elloramycins are typified by a shared oxidatively modified linear
decaketide core, yet they are distinguished by the extent of O-methylation
and the presence of a 2′,3′,4′-tri-O-methyl-α-l-rhamnose appended at the 8-position of
elloramycin. The transfer of the TDP-l-rhamnose donor to
the 8-demethyl-tetracenomycin C aglycone acceptor is catalyzed by
the promiscuous glycosyltransferase ElmGT. ElmGT exhibits remarkable
flexibility toward transfer of many TDP-deoxysugar substrates to 8-demethyltetracenomycin
C, including TDP-2,6-dideoxysugars, TDP-2,3,6-trideoxysugars, and
methyl-branched deoxysugars in both d- and l-configurations.
Previously, we developed an improved host, Streptomyces
coelicolor M1146::cos16F4iE, which is a stable integrant
harboring the required genes for 8-demethyltetracenomycin C biosynthesis
and expression of ElmGT. In this work, we developed BioBricks gene
cassettes for the metabolic engineering of deoxysugar biosynthesis
in Streptomyces spp. As a proof of concept, we used
the BioBricks expression platform to engineer biosynthesis for d-configured TDP-deoxysugars, including known compounds 8-O-d-glucosyl-tetracenomycin C, 8-O-d-olivosyl-tetracenomycin C, 8-O-d-mycarosyl-tetracenomycin C, and 8-O-d-digitoxosyl-tetracenomycin
C. In addition, we generated four new tetracenomycins including one
modified with a ketosugar, 8-O-4′-keto-d-digitoxosyl-tetracenomycin C, and three modified with 6-deoxysugars,
including 8-O-d-fucosyl-tetracenomycin C,
8-O-d-allosyl-tetracenomycin C, and 8-O-d-quinovosyl-tetracenomycin C. Our work demonstrates
the feasibility of BioBricks cloning, with the ability to recycle
intermediate constructs, for the rapid assembly of diverse carbohydrate
pathways and glycodiversification of a variety of natural products.